Search

everythinglearnresearchcommunity

for

Search:↓

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Oral testosterone therapy raises heart risk more than other methods.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Scrotal rejuvenation treats aging-related changes in men's scrotum using methods like medication, hair transplantation, and surgery.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone increases hair growth and acne in transgender men.